Mayne Pharma | MYX - 股本和储备

股票价格
2.24
每天变化
0.08 3.70%
每月一次
-15.47%
每年
-67.91%
Q2 预测
2.19


金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD -0.15
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 190.57M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 212.07M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


股本和储备 更改 日
Ansell USD 1.97B 10.2M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Healius AUD 1.03B 13.9M 2024-12
Integral Diagnostics AUD 301.71M 1.33M 2024-06
Medical Developments International AUD 54.77M 335K 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Polynovo AUD 83.14M 121K 2025-12
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.32B 199.62M 2025-12
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12